Figure 1: A) Axial slice of a fluid attenuated inversion recovery (FLAIR) sequence MRI with normal appearing left trigeminal nerve. B) Axial slice of a fat-saturated proton-density weighted 3D transient-spin-echo (SPACE) sequence showing a normal appearing trigeminal nerve. C) Axial slice of a magnetization-prepared rapid acquisition with gradient echo (MP-
abnormal and enlarged with some mass effect on the adjacent pons ( Figure 2A ). The lesion was greyish-tan in color, and dense with no way to separate tumor and nerve. Biopsies were taken, and the frozen section specimens were consistent with malignancy. Post-operatively, the patient's condition deteriorated with the development of confusion, somnolence, and incontinence. The MRI revealed extensive, non-enhancing, signal change throughout the deep grey matter and frontal lobes bilaterally ( Figure 1D ). The final biopsy pathology showed a diffuse growth pattern with prominent infiltration of the nerve by atypical lymphocytes with centroblastic features ( Figure 3A ). Immunohistochemical studies showed staining of large cells by CD20 ( Figure 3B ), CD45, BCL2, and MUM-1 (B-cell markers). Also, 80-90% of the cells stained positive for Ki-67 with marker MIB-1 ( Figure 3C ) showing marked cellularity, in keeping with the diagnosis of diffuse large B-cell lymphoma (DLBCL).
After obtaining the diagnosis, the patient was started on chemotherapy including one cycle of methotrexate (3.5g/m 2 ), procarbazine (100mg/m 2 ), and vincristine (1.4mg/m 2 ), followed by a second cycle of methotrexate (3.5g/m 2 ), rituximab (350mg/m 2 ), and cytarabine (2g/m 2 ). The patient responded well to this regimen with resolution of his pain and confusion. The MRI and PET studies showed resolution of the lymphoma ( Figure 1E and F), and he went on to have an autologous stem cell transplant. At six month follow-up, he had made a good recovery from the transplant with examination finding only leftsided numbness in the V1 and V2 trigeminal distribution, and a weak corneal reflex.
DISCUSSION
Primary central nervous system lymphoma is usually of NonHodgkin B-cell origin, and typically arises in the periventricular white matter or deep nuclei. Few reports characterize skull base THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES lymphomatous tumors [1] [2] [3] [4] [5] , and even fewer describe primary lymphomatous tumors of the trigeminal nerve 1, 3 . This case highlights a rare presentation of PCNSL as a facial pain syndrome with initial investigations being negative, and subsequent progression of the disease showing trigeminal nerve enhancement. This patient has done well with chemotherapy and stem-cell transplant, although relapse for these tumors is not uncommon. Close follow-up with the patient will be essential.
There are few reports describing the diagnostic difficulty of these lesions, with misdiagnoses of lymphomatous tumors as both schwannomas and meningiomas noted 1, 5 . These cases have resulted in unnecessary, more extensive surgeries. Here, we selected a retrosigmoid approach for nerve biopsy, although percutaneous needle biopsy of Meckel's cave lesions has been previously described 3 . For tumors such as this one infiltrating into Meckel's cave, the percutaneous approach is a less invasive, and perhaps better alternative.
CONCLUSION
This case describes the rare occurrence of a primary trigeminal nerve lymphoma presenting as trigeminal neuralgia. Although this tumor was diagnosed via open biopsy of the nerve, it is important to first rule out other more common possibilities. These lesions present a significant diagnostic challenge, and it is important to keep lymphoma in the differential diagnosis as the role of surgery is limited to tissue diagnosis.
